SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Malcolm G. Semple, Helen M. E. Duyvesteyn et al.|Cell|2022Cited by 1k
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Gavin Screaton, Rungtiwa Nutalai et al.|Cell|2022Cited by 762
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19Jiandong Huo, Raymond J. Owens|Nature Communications|2021Cited by 154